Report Detail
COVID-19 Impact on Global Outsourcing in Drug Development Market Size, Status and Forecast 2020-2026
- RnM3984833 |
- 03 June, 2020 |
- Global |
- 90 Pages |
- QYResearch |
- Service & Software
For a biopharmaceutical industry in flux, outsourcing services are playing a greater and more diverse role in drug development.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Outsourcing in Drug Development market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Outsourcing in Drug Development industry.
Based on our recent survey, we have several different scenarios about the Outsourcing in Drug Development YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Outsourcing in Drug Development will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Outsourcing in Drug Development market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Outsourcing in Drug Development market in terms of revenue.
Players, stakeholders, and other participants in the global Outsourcing in Drug Development market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Outsourcing in Drug Development market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Outsourcing in Drug Development market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Outsourcing in Drug Development market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Outsourcing in Drug Development market.
The following players are covered in this report:
Charles River Laboratories
Covance
ICON
Parexel
Quintiles Transnational
PPD
PRA Health Sciences
...
Outsourcing in Drug Development Breakdown Data by Type
Clinical Trials
New Drug Application
Outsourcing in Drug Development Breakdown Data by Application
Pharmaceutical Industries
Biotechnology Industries
Medical Device Industries
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Outsourcing in Drug Development Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Outsourcing in Drug Development Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Clinical Trials
- 1.4.3 New Drug Application
- 1.5 Market by Application
- 1.5.1 Global Outsourcing in Drug Development Market Share by Application: 2020 VS 2026
- 1.5.2 Pharmaceutical Industries
- 1.5.3 Biotechnology Industries
- 1.5.4 Medical Device Industries
- 1.6 Coronavirus Disease 2019 (Covid-19): Outsourcing in Drug Development Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Outsourcing in Drug Development Industry
- 1.6.1.1 Outsourcing in Drug Development Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Outsourcing in Drug Development Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Outsourcing in Drug Development Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Outsourcing in Drug Development Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Outsourcing in Drug Development Market Perspective (2015-2026)
- 2.2 Outsourcing in Drug Development Growth Trends by Regions
- 2.2.1 Outsourcing in Drug Development Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Outsourcing in Drug Development Historic Market Share by Regions (2015-2020)
- 2.2.3 Outsourcing in Drug Development Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Outsourcing in Drug Development Market Growth Strategy
- 2.3.6 Primary Interviews with Key Outsourcing in Drug Development Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Outsourcing in Drug Development Players by Market Size
- 3.1.1 Global Top Outsourcing in Drug Development Players by Revenue (2015-2020)
- 3.1.2 Global Outsourcing in Drug Development Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Outsourcing in Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Outsourcing in Drug Development Market Concentration Ratio
- 3.2.1 Global Outsourcing in Drug Development Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Outsourcing in Drug Development Revenue in 2019
- 3.3 Outsourcing in Drug Development Key Players Head office and Area Served
- 3.4 Key Players Outsourcing in Drug Development Product Solution and Service
- 3.5 Date of Enter into Outsourcing in Drug Development Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Outsourcing in Drug Development Historic Market Size by Type (2015-2020)
- 4.2 Global Outsourcing in Drug Development Forecasted Market Size by Type (2021-2026)
5 Outsourcing in Drug Development Breakdown Data by Application (2015-2026)
- 5.1 Global Outsourcing in Drug Development Market Size by Application (2015-2020)
- 5.2 Global Outsourcing in Drug Development Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Outsourcing in Drug Development Market Size (2015-2020)
- 6.2 Outsourcing in Drug Development Key Players in North America (2019-2020)
- 6.3 North America Outsourcing in Drug Development Market Size by Type (2015-2020)
- 6.4 North America Outsourcing in Drug Development Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Outsourcing in Drug Development Market Size (2015-2020)
- 7.2 Outsourcing in Drug Development Key Players in Europe (2019-2020)
- 7.3 Europe Outsourcing in Drug Development Market Size by Type (2015-2020)
- 7.4 Europe Outsourcing in Drug Development Market Size by Application (2015-2020)
8 China
- 8.1 China Outsourcing in Drug Development Market Size (2015-2020)
- 8.2 Outsourcing in Drug Development Key Players in China (2019-2020)
- 8.3 China Outsourcing in Drug Development Market Size by Type (2015-2020)
- 8.4 China Outsourcing in Drug Development Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Outsourcing in Drug Development Market Size (2015-2020)
- 9.2 Outsourcing in Drug Development Key Players in Japan (2019-2020)
- 9.3 Japan Outsourcing in Drug Development Market Size by Type (2015-2020)
- 9.4 Japan Outsourcing in Drug Development Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Outsourcing in Drug Development Market Size (2015-2020)
- 10.2 Outsourcing in Drug Development Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Outsourcing in Drug Development Market Size by Type (2015-2020)
- 10.4 Southeast Asia Outsourcing in Drug Development Market Size by Application (2015-2020)
11 India
- 11.1 India Outsourcing in Drug Development Market Size (2015-2020)
- 11.2 Outsourcing in Drug Development Key Players in India (2019-2020)
- 11.3 India Outsourcing in Drug Development Market Size by Type (2015-2020)
- 11.4 India Outsourcing in Drug Development Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Outsourcing in Drug Development Market Size (2015-2020)
- 12.2 Outsourcing in Drug Development Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Outsourcing in Drug Development Market Size by Type (2015-2020)
- 12.4 Central & South America Outsourcing in Drug Development Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Charles River Laboratories
- 13.1.1 Charles River Laboratories Company Details
- 13.1.2 Charles River Laboratories Business Overview and Its Total Revenue
- 13.1.3 Charles River Laboratories Outsourcing in Drug Development Introduction
- 13.1.4 Charles River Laboratories Revenue in Outsourcing in Drug Development Business (2015-2020))
- 13.1.5 Charles River Laboratories Recent Development
- 13.2 Covance
- 13.2.1 Covance Company Details
- 13.2.2 Covance Business Overview and Its Total Revenue
- 13.2.3 Covance Outsourcing in Drug Development Introduction
- 13.2.4 Covance Revenue in Outsourcing in Drug Development Business (2015-2020)
- 13.2.5 Covance Recent Development
- 13.3 ICON
- 13.3.1 ICON Company Details
- 13.3.2 ICON Business Overview and Its Total Revenue
- 13.3.3 ICON Outsourcing in Drug Development Introduction
- 13.3.4 ICON Revenue in Outsourcing in Drug Development Business (2015-2020)
- 13.3.5 ICON Recent Development
- 13.4 Parexel
- 13.4.1 Parexel Company Details
- 13.4.2 Parexel Business Overview and Its Total Revenue
- 13.4.3 Parexel Outsourcing in Drug Development Introduction
- 13.4.4 Parexel Revenue in Outsourcing in Drug Development Business (2015-2020)
- 13.4.5 Parexel Recent Development
- 13.5 Quintiles Transnational
- 13.5.1 Quintiles Transnational Company Details
- 13.5.2 Quintiles Transnational Business Overview and Its Total Revenue
- 13.5.3 Quintiles Transnational Outsourcing in Drug Development Introduction
- 13.5.4 Quintiles Transnational Revenue in Outsourcing in Drug Development Business (2015-2020)
- 13.5.5 Quintiles Transnational Recent Development
- 13.6 PPD
- 13.6.1 PPD Company Details
- 13.6.2 PPD Business Overview and Its Total Revenue
- 13.6.3 PPD Outsourcing in Drug Development Introduction
- 13.6.4 PPD Revenue in Outsourcing in Drug Development Business (2015-2020)
- 13.6.5 PPD Recent Development
- 13.7 PRA Health Sciences
- 13.7.1 PRA Health Sciences Company Details
- 13.7.2 PRA Health Sciences Business Overview and Its Total Revenue
- 13.7.3 PRA Health Sciences Outsourcing in Drug Development Introduction
- 13.7.4 PRA Health Sciences Revenue in Outsourcing in Drug Development Business (2015-2020)
- 13.7.5 PRA Health Sciences Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Outsourcing in Drug Development. Industry analysis & Market Report on COVID-19 Impact on Global Outsourcing in Drug Development is a syndicated market report, published as COVID-19 Impact on Global Outsourcing in Drug Development Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Outsourcing in Drug Development market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
